跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
萘敏维滴眼液 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Naphazoline Hydrochloride,Chlorphenamine Maleate and Vitamin B12 Eye Drops
Approved
化学药品
Naphazoline Hydrochloride,Chlorphenamine Maleate and Vitamin B12 Eye Drops
石家庄格瑞药业有限公司
🇨🇳 National Medical Products Administration
Approval Date
Jul 27, 2026
Approval ID
8nbuxWkFyO8
Company
石家庄格瑞药业有限公司
Type
化学药品
Approval Details
Approval Id
8nbuxWkFyO8
Approval Number
国药准字H20269175
Generic Name
萘敏维滴眼液
Generic Name En
Naphazoline Hydrochloride,Chlorphenamine Maleate and Vitamin B12 Eye Drops
Drug Type
化学药品
Dosage Form
眼用制剂
Strength
0.4ml:盐酸萘甲唑啉0.008mg与马来酸氯苯那敏0.08mg与维生素B12 0.04mg
Reg Date
2026-07-27
Company Name
石家庄格瑞药业有限公司
Company Address
石家庄高新区秦岭大街588号
Production Company Name
石家庄格瑞药业有限公司
Production Company Address
石家庄高新区秦岭大街588号
Company Detail Path
/organization/shi-jia-zhuang-ge-rui-yao-ye-you-xian-gong-si
Production Company Detail Path
/organization/shi-jia-zhuang-ge-rui-yao-ye-you-xian-gong-si
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jul 27, 2026
Approval ID
8nbuxWkFyO8
Type
化学药品
Back to NMPA Approvals